Virax Biolabs Group Ltd (VRAX) Price Prediction & ForecastVRAXForecastVirax Biolabs Group Ltd

Alphio's VRAX stock price prediction model matches the current Virax Biolabs Group Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.85 (+1.09%). The 1-week path is $3.15 (+11.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, Virax Biolabs Group Ltd (VRAX) is not a strong buy due to its significant year-to-date decline of 70.62% and a negative forward P/E ratio of 0, indicating potential challenges in future earnings. The RSI is at 42.168, suggesting the stock is nearing oversold conditions, but the recent 5-day change of -11.60% raises concerns about short-term momentum. The main risk is its low trading volume of 37,110 compared to an average of 1,008,051, indicating a lack of investor interest and liquidity.

Virax Biolabs Group Ltd (VRAX) last closed at $2.82, losing -4.08%. These facts feed the 1-day and 1-week VRAX price prediction above.